Global Prescription Dermatological Drugs Market Size, Status and Forecast 2025

Publisher Name :
Date: 12-Jun-2018
No. of pages: 95
Inquire Before Buying

This report studies the global Prescription Dermatological Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Prescription Dermatological Drugs market by companies, region, type and end-use industry.

In 2017, the global Prescription Dermatological Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered

Johnson & Johnson

Merck

Bayer

Mylan Pharmaceuticals

Pfizer

F. Hoffmann-La Roche

Allergan

Valeant Pharmaceuticals

PharmaDerm Pharmaceuticals

Allergan Inamed Corporation

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Market segment by Type, the product can be split into

Anti-acne Drugs

Anti-aging Drugs

Dermatitis Drugs

Hair Loss Drugs

Psoriasis Drugs

Skin Cancer Drugs

Melasma Drugs

Seborrhea Drugs

Market segment by Application, split into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The study objectives of this report are:

To study and forecast the market size of Prescription Dermatological Drugs in global market.

To analyze the global key players, SWOT analysis, value and global market share for top players.

To define, describe and forecast the market by type, end use and region.

To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Prescription Dermatological Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Prescription Dermatological Drugs Manufacturers

Prescription Dermatological Drugs Distributors/Traders/Wholesalers

Prescription Dermatological Drugs Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Prescription Dermatological Drugs market, by end-use.

Detailed analysis and profiles of additional market players.

Global Prescription Dermatological Drugs Market Size, Status and Forecast 2025

Table of Contents
Global Prescription Dermatological Drugs Market Size, Status and Forecast 2025
1 Industry Overview of Prescription Dermatological Drugs
1.1 Prescription Dermatological Drugs Market Overview
1.1.1 Prescription Dermatological Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Prescription Dermatological Drugs Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Prescription Dermatological Drugs Market by Type
1.3.1 Anti-acne Drugs
1.3.2 Anti-aging Drugs
1.3.3 Dermatitis Drugs
1.3.4 Hair Loss Drugs
1.3.5 Psoriasis Drugs
1.3.6 Skin Cancer Drugs
1.3.7 Melasma Drugs
1.3.8 Seborrhea Drugs
1.4 Prescription Dermatological Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 Global Prescription Dermatological Drugs Competition Analysis by Players
2.1 Prescription Dermatological Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Johnson & Johnson
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.2 Merck
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.3 Bayer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.4 Mylan Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.5 Pfizer
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.6 F. Hoffmann-La Roche
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.7 Allergan
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.8 Valeant Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.9 PharmaDerm Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.10 Allergan Inamed Corporation
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
4 Global Prescription Dermatological Drugs Market Size by Type and Application (2013-2018)
4.1 Global Prescription Dermatological Drugs Market Size by Type (2013-2018)
4.2 Global Prescription Dermatological Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Prescription Dermatological Drugs in Future
4.4 Top Consumer/End Users of Prescription Dermatological Drugs
5 United States Prescription Dermatological Drugs Development Status and Outlook
5.1 United States Prescription Dermatological Drugs Market Size (2013-2018)
5.2 United States Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Prescription Dermatological Drugs Market Size by Application (2013-2018)
6 Europe Prescription Dermatological Drugs Development Status and Outlook
6.1 Europe Prescription Dermatological Drugs Market Size (2013-2018)
6.2 Europe Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
6.3 Europe Prescription Dermatological Drugs Market Size by Application (2013-2018)
7 China Prescription Dermatological Drugs Development Status and Outlook
7.1 China Prescription Dermatological Drugs Market Size (2013-2018)
7.2 China Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
7.3 China Prescription Dermatological Drugs Market Size by Application (2013-2018)
8 Japan Prescription Dermatological Drugs Development Status and Outlook
8.1 Japan Prescription Dermatological Drugs Market Size (2013-2018)
8.2 Japan Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
8.3 Japan Prescription Dermatological Drugs Market Size by Application (2013-2018)
9 Southeast Asia Prescription Dermatological Drugs Development Status and Outlook
9.1 Southeast Asia Prescription Dermatological Drugs Market Size (2013-2018)
9.2 Southeast Asia Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Prescription Dermatological Drugs Market Size by Application (2013-2018)
10 India Prescription Dermatological Drugs Development Status and Outlook
10.1 India Prescription Dermatological Drugs Market Size (2013-2018)
10.2 India Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
10.3 India Prescription Dermatological Drugs Market Size by Application (2013-2018)
11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Prescription Dermatological Drugs Market Size (Value) by Regions (2018-2025)
11.1.1 United States Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.2 Europe Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.3 China Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.4 Japan Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.5 Southeast Asia Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.6 India Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Prescription Dermatological Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Prescription Dermatological Drugs Market Size by Application (2018-2025)
12 Prescription Dermatological Drugs Market Dynamics
12.1 Prescription Dermatological Drugs Market Opportunities
12.2 Prescription Dermatological Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Prescription Dermatological Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Prescription Dermatological Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Global Prescription Dermatological Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Prescription Dermatological Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Prescription Dermatological Drugs Market Share by Regions (2013-2018)
Figure United States Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Prescription Dermatological Drugs Revenue Market Share by Type in 2017
Figure Anti-acne Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Anti-aging Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Dermatitis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Hair Loss Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Psoriasis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Skin Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Melasma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Seborrhea Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Prescription Dermatological Drugs Market Share by Application in 2017
Figure Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2013-2018)
Figure Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2013-2018)
Figure Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2013-2018)
Table Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Johnson & Johnson Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
Figure Johnson & Johnson Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Merck Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Bayer Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Bayer (2013-2018)
Figure Bayer Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Mylan Pharmaceuticals Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Mylan Pharmaceuticals (2013-2018)
Figure Mylan Pharmaceuticals Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
Figure F. Hoffmann-La Roche Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Allergan Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Allergan (2013-2018)
Figure Allergan Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Valeant Pharmaceuticals Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals (2013-2018)
Figure Valeant Pharmaceuticals Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table PharmaDerm Pharmaceuticals Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of PharmaDerm Pharmaceuticals (2013-2018)
Figure PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Allergan Inamed Corporation Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Allergan Inamed Corporation (2013-2018)
Figure Allergan Inamed Corporation Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Prescription Dermatological Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Prescription Dermatological Drugs Market Share by Product in 2017
Table Global Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Global Prescription Dermatological Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Prescription Dermatological Drugs
Figure United States Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure United States Prescription Dermatological Drugs Market Size Share by Players in 2017
Table United States Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure United States Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Europe Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Europe Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Europe Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Europe Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Europe Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Europe Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure China Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure China Prescription Dermatological Drugs Market Size Share by Players in 2017
Table China Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure China Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Japan Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Japan Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Japan Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Japan Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Southeast Asia Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Southeast Asia Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Southeast Asia Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure India Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure India Prescription Dermatological Drugs Market Size Share by Players in 2017
Table India Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure India Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Global Prescription Dermatological Drugs Market Size and Growth Rate (2018-2025)
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size Share (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size Share by Regions in 2025
Figure United States Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size Share by Type in 2018
Figure Global Prescription Dermatological Drugs Market Size Share by Type in 2025
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size (Million USD) by Application in 2018
  • Global Plethysmometer Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 117
    Plethysmometer is designed to provide a highly useful tool in the measurement of small volume changes. This test is typically used to follow the evolution of the inflammatory response experimentally induced in rodents and to screen potential anti-inflammatory or anti-oedema properties of pharmacological substances. The global Plethysmometer market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objective......
  • Global Algometer Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 116
    Algometer is software-based computerized Algometer to offer real-time visual and auditory feedback to control and monitor applied pressure rates. The global Algometer market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Algometer market based on company, product type, end user and key regions. This report studies......
  • Global Schizoaffective Disorders Treatment Market Size, Status and Forecast 2018-2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 99
    Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders. The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. In 2017, the global Schizoaffective Disorders Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global Schizoaffective Disorders Treatm......
  • Global Rubella Diagnostic Testing Market Size, Status and Forecast 2018-2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 96
    Rubella infection generally affects children and adults. This infection has a serious effect on pregnant women and may result in fetal death or congenital defects. Geographically, the entire rubella diagnostic testing market is classified into North America, Europe, Asia Pacific, Latin America and MEA. In 2017, the global Rubella Diagnostic Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.......
  • Global Respiratory Syncytial Virus Diagnostics Market Size, Status and Forecast 2018-2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 107
    Products of the respiratory syncytial virus diagnostics market includes direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others. North America dominates the market for respiratory syncytial virus diagnosis because of the rising incidence of these infections and the increasing number of babies. In addition, the medical system continues to evolve, a......
  • Global Respiratory Disease Testing/Diagnostics Market Size, Status and Forecast 2018-2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 105
    Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters. The prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma and other respiratory infections, as well as the increasing popularity of portable devices such as advanced respirometers and non-invasive ventilators are the leading causes of North America. In 2017, the global Respiratory Disease Testing/Diagnosti......
  • Global Renal Disease Treatment Devices Market Size, Status and Forecast 2018-2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 90
    Renal Disease Treatment Devices are subdivided into urinary treatment, dialysis, pelvic organ prolapse treatment, endoscopic, benign prostatic hyperplasia treatment equipment, prostate stent, gravel, sacral nerve regulation, urethral insertion and pessary, urethral stent, vaginal network Sleeve and sling, peritoneal dialysis, catheter ablation, urolithiatherapy, etc. North America is the largest market, thanks to advanced medical facilities and government support policies. The increase in......
  • Global Pulmonary Drug Delivery Devices/Systems Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 4900 Onwards        Pages: 116
    Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories. North America dominates the dominant drug delivery devices/systems market position. Major local pharmaceutical and medical device manufacturers, advanced medical infrastructure, population ageing, high disposable income and lifestyle changes are all factors driving the overall growth of the North American pharmaceutical drug delivery devices/systems market. The glob......
  • Global Portable Medical Electronics Products Market Size, Status and Forecast 2018-2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 94
    Portable Medical Electronics Products increases patient mobility, enhances healthcare standards, delivers quality care, delivers personalized care, reduces errors and high patient satisfaction. North America has the largest share of the portable medical electronics market due to important factors such as the rising prevalence of chronic diseases and rising elderly population. In 2017, the global Portable Medical Electronics Products market size was xx million US$ and it is expected......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs